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Abstract
Background—Depression and anxiety have been inconsistently associated with diabetes. Sex 
differences in the biological and behavioral correlates of these forms of distress could partially 
explain these inconsistencies. We investigated sex-specific associations between depression/
anxiety symptomatology and diabetes in two separate samples.
Methods—The First National Health and Nutrition Examination Survey (NHANES) enrolled 
3,233 participants aged 25–74 years from 1971–1974. Depression and anxiety symptoms were 
measured via General Well Being schedule subscales. Incident diabetes over 17 years was defined 
by: i) death certificate; ii) participant self-report; or iii) healthcare facility discharge. The Detroit 
Neighborhood Health Study (DNHS) enrolled 1,054 participants aged 18 years or older, from 
2008–2010. The Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7 assessed 
depression and anxiety. Participants’ self-reported physician diagnosed prevalent diabetes.
Results—In NHANES the RR [95%CI] for incident diabetes among men with high vs. low 
anxiety symptoms was 0.85 [0.56–1.29] and among women 2.19 [1.17–4.09], P for 
interaction=0.005. Risk ratios (RRs) comparing high vs. low depressive symptoms for men and 
women were 0.69 [0.43–1.10] and 2.11 [1.06–4.19], P for interaction=0.007. In DNHS, the RRs 
for prevalent diabetes comparing those with high vs. low anxiety symptoms were 0.24 [0.02–2.42] 
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for men and 1.62[0.61–4.32] for women, P for interaction=<0.001 while RRs for depression were 
1.30[0.46–3.68] for men and 2.32[1.10–4.89] for women, P for interaction=0.16.
Conclusion—In two separate samples, depressive symptoms were related to increased diabetes 
risk among women but not men. While less robust, findings for anxiety were differentially 
associated with diabetes by sex.
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INTRODUCTION
Depression and anxiety have been linked to increased risk of incident diabetes in several 
previous studies with most research focusing specifically on diabetes risk as it relates to 
depression (1,2,3,4,5,6,7,8,9,10,11,12,13,14,15). Two previous meta-analyses have 
summarized the current longitudinal literature and concluded that higher baseline depression 
levels are associated with a statistically significant increase in incident diabetes rates, 
although both reports also observed heterogeneity of associations across studies (16,17). 
One possible source of heterogeneity is differential strength of association between 
depression and diabetes by sex, although this possibility could not be explored because 
surprisingly few studies have reported sex-specific results. Only 1 of 9 studies analyzed by 
Knol et al. and 2 of 13 studies analyzed by Mezuk et al. included sex-specific results; in both 
meta-analyses, measures of association were pooled for the meta-analysis. Therefore, little is 
known about the potential for sex differences in these associations. Furthermore, most 
studies have focused on depression, and despite findings that other cardiometabolic diseases 
are also associated with anxiety, few studies exist considering anxiety in relation to diabetes 
risk (13,14).
Exploring whether depression and/or anxiety are differentially related to diabetes risk among 
men as compared with women is justified for at least four reasons. First, sex is an easily 
identifiable characteristic, simplifying risk stratification for clinical and public health 
purposes. Second, there is precedent for sex-specific diabetes risk in regard to several other 
factors including obesity, sex hormones, infection and inflammation (18,19,20,21,22,23). 
Differences of this nature underlie the NIH policy requiring the inclusion of women in 
human studies beginning in 1993 and in preclinical cell and animal studies beginning in 
2014 (24). Third, a sex-specific relationship between mental health and diabetes is 
biologically plausible. For example, women tend to have higher levels of psychosocial risk 
than men (e.g., lower levels of education and income, more likely to be a single parent), 
which could exacerbate effects of distress (25,26). Moreover, other research has 
demonstrated that effects on disease risk are often stronger in women. Some work has 
suggested that the heightened effects are due in part to a stronger effect of psychosocial risk 
factors on risk of overweight and obesity in women as compared with men (25). This may 
be because men and women cope with depression and anxiety differently (27,28,29,30,31) 
and these coping mechanisms, in turn, influence diet, physical activity and ultimately 
adiposity and diabetes risk. It has also been suggested that sexually dimorphic biological 
responses to stress could influence diabetes-risk in men and women differently (31). For 
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example, there is evidence that the interplay between mental health, inflammation and the 
hypothalamic-pituitary-adrenal (HPA) axis may differ by sex with women showing greater 
dysregulation, and both inflammation and HPA axis dysregulation have been linked to 
insulin resistance and diabetes (32,30,33,31). Finally, if depression and/or anxiety 
contributed differentially to diabetes risk, it could help explain the similarity in sex-specific 
diabetes prevalence estimates (34,35) despite the fact that men have a higher prevalence of 
traditional cardiometabolic risk factors (36). Higher prevalence (or stronger influence) of 
novel risk factors among women might counter-balance the influence of traditional risk 
factors on T2D prevalence throughout the lifecourse.
We investigate sex differences in the association of depression or anxiety symptoms with 
risk of both incident and prevalent diabetes using a nationally-representative sample of 
diabetes-free adults enrolled in the First National Health and Nutrition Examination Survey 
(NHANES I) and Its Epidemiological Follow-Up Study (NHEFS). While data collection 
were completed in NHEFS in 1992, we do not anticipate that the relationships under study 
would alter significantly in the intervening period, and in fact findings are informative for a 
substantial population of older adults currently at risk. However, to ensure findings remain 
relevant today and to address the lack of racial diversity in NHANES, we also assess the 
relationship between depression and anxiety symptomatology and prevalent diabetes in a 
separate population-based sample of adults enrolled in the Detroit Neighborhood Health 
Study (DNHS).
METHODS
NHANES I was a national probability sample of the non-institutionalized U.S. population 
aged 1–74 years, conducted during 1971–1974. NHEFS was a longitudinal study of 14,407 
NHANES I participants initially 25–74 years of age who completed a medical examination 
(37,23). NHEFS includes four longitudinal follow-up studies in 1982–1984, 1986, 1987 and 
1992. Ninety-six percent of the study population was successfully traced through the 1992 
follow-up. Death certificates were sought for all deceased participants. 3,555 NHANES 
participants who were administered the General Well-Being (GWB) Schedule, a baseline 
diabetes questionnaire and received at least one follow-up interview were eligible for the 
present analysis. Among these, participants were excluded due to missing covariates, 
prevalent diabetes or a participant’s report of “other” for race (due to low sample size), 
yielding a final sample of 3,233.
Detroit Neighborhood Health Study
The Detroit Neighborhood Health Study (DNHS) is a longitudinal cohort of adults in 
Detroit, Michigan (38). Participants were selected by dual-frame probability design, using 
list-assisted random-digit-dial as well as telephone numbers obtained from U.S. Postal 
Service Delivery Sequence Files. Wave 1 was conducted from 2008–2009 and enrolled 
1,547 participants. Wave 2 included 1,054. Wave 1 participants who were reinterviewed one 
year later (1050 included presently).
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Assessment of Depression and Anxiety Symptomatology
In NHANES, depressive and anxious symptoms were measured using the General Well-
Being Schedule (GWB), a validated measure with known psychometric properties (39,40). 
Participants were assessed during NHANES I by trained interviewers. Two of six GWB 
subscales were used in these analyses: cheerful versus depressed mood (General Well-Being 
Schedule Depression subscale, GWB-D) and relaxed versus tense/anxious (General Well-
Being Schedule Anxiety subscale, GWB-A). The GWB-D and GWB-A each yield subscale 
scores ranging from 0 to 25, with low values indicating more depressive or anxious 
symptoms. GWB-A and GWB-D subscale scores were used to categorize participants into 
sex-specific tertiles of anxiety and depression. In sensitivity analyses, we also categorized 
participants according to clinical cut points in which scale scores of 0 to 12 indicated high, 
13 to 18 indicated moderate, and 19 to 25 indicated low symptomatology, as previously 
described (41,4). The overall GWB has sound psychometric properties (42,40).
In DNHS, depression and anxiety symptoms were measured in Wave 1 using DSM IV 
symptomatology criteria collected via modified versions of the Patient Health Questionnaire 
(PHQ-9) and The Generalized Anxiety Disorder Questionnaire (GAD-7). Depression 
symptom scores from the PHQ-9 scale were used to categorize participants into three groups 
according to clinically validated cut-off points (0, 1–2, 3+). Similarly, GAD-7 symptom 
scores were used to categorize participants into three groups (0–9, 10–14, 15+) according to 
clinical cut-off points (43). Clinical reappraisal using clinician interviews in this sample 
showed good concordance between the measures and diagnoses using the Structured 
Clinical Interview for DSM-IV (SCID)(38).
Incident Diabetes in NHANES
Incident diabetes was defined by: i) death certificate: International Classification of 
Diseases, Ninth Revision (ICD)-9 code in the range of 250.0–250.9, or diabetes otherwise 
listed on the death certificate; ii) self-reported physician diagnosis requiring 
pharmacological treatment: participants reporting physician diagnosed diabetes and dietary 
intervention but not pharmacological intervention were not considered to have developed 
incident diabetes to enhance outcome specificity; or iii) health care facility stay with 
diabetes discharge diagnosis.
Prevalent Diabetes in DNHS
Diabetes status was determined via self-report of physician-diagnosed diabetes in Wave 2 
(~one year after depression and anxiety assessments). Given the short follow-up time 
between waves 1 and 2, all diabetes cases are assumed to be prevalent at wave 1 (38).
Risk Factor Data Collection
In NHANES, potential confounding (or mediating) variables related to diabetes risk and/or 
indicative of healthy lifestyle were collected during the baseline evaluation including age, 
race (African American, or White), poverty index (total household income in the numerator 
and total income necessary to maintain the family on a nutritionally adequate food plan in 
the denominator; values>1 indicate incomes above poverty), education level (<high school, 
high school graduate, >high school education), post-menopausal status (self-report complete 
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cessation of menstruation), body mass index (BMI, weight in kilograms divided by height in 
meters squared based on in-person measures), physical activity and smoking status (current, 
former, never) as previously described (23). Similarly, DNHS covariables assessed include 
age, gender, race, employment, marital status, education, binge drinking (five or more drinks 
on a single drinking occasion in the past month for men; four or more for women) and 
cigarette smoking (any lifetime smoking). BMI data were not available in DNHS.
Statistical analysis
Survey procedures in SAS version 9.3 and SAS-callable SUDAAN version 10 were used for 
analyses. The NHANES and DNHS samples were analyzed separately. Our main results are 
based on the NHANES sample because these data were longitudinal and provide clarity 
regarding temporality of exposure-outcome relationships while DNHS results provide an 
alternative and valuable cohort with which to compare NHANES findings and reduce the 
potential for false-positive findings.
In each sample, we performed the following specific analyses. First, distributions of several 
potential diabetes risk factors were presented according to sex and category of 
symptomatology (defined above). Chi-square and ANOVA tests were conducted to 
determine statistical significance of variation in risk factors according to both depression 
and anxiety symptomatology.
Next, we used multivariable regression models to regress the probability of either incident 
diabetes (NHANES) or prevalent diabetes (DNHS) across categories of depression or 
anxiety; main effects regressions were performed separately for depression and anxiety 
symptoms. Additional regression models assessed associations in sex subgroups. Finally, 
formal tests for interaction were performed using an interaction model which included 
variables for sex, depression or anxiety symptoms and a sex*depression or anxiety symptom 
interaction term; in our interaction model, we operationalized depression and anxiety 
symptom level as an ordinal variable in tertiles.
PROC RLOGIST in SUDAAN was used to account for the stratification, clustering and 
sample weights used in both NHANES and DNHS and to obtain multivariable adjusted risk 
ratios from fitted logistic regression models by obtaining point estimates of model-adjusted 
risk ratios (RR) as functions of average marginal predictions (44). Results from crude and 
adjusted regression models are presented to provide clarity regarding confounding.
RESULTS
NHANES
In the NHANES sample, participants were 52% female, 86% White, and 14% African 
American. Mean age±standard deviation (STD) at baseline was 49±14 years. The 
cumulative incidence of diabetes was 9.2% (n=298 cases) during an average follow-up time 
of 17 years and the risk was higher among men (11%) than among women (8%), P<0.01. 
Death certificates were the lone source of incident diabetes determination for only 2 cases 
and 40% of cases were confirmed by >one source (Table 1). There was no evidence that 
diabetes ascertainment differed by gender (Table 1).
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Mean±STD GWB scores for anxiety and depressive symptoms were 18.2±5.0 and 18.6±4.3. 
Men had higher (indicating less symptomatology) mean scores±standard error (SE) than 
women for anxiety and depressive symptoms: anxiety symptoms=18.5±0.2 vs. 17.5±0.2 
(P<0.0001) and depressive symptoms=19.3±0.2 vs. 18.1±0.2 (P<0.0001). Increased anxiety 
symptoms (3rd vs. 1st tertile) was associated with an average age that was 4 years younger 
among men (P<0.0001) and 2 years younger among women (P<0.001). This trend was 
similar for depressive symptoms among women while, in contrast, men with higher 
depression symptomatology were three years older than men with lower symptomatology 
(Tables S1 and S2, Supplemental Digital Content 1). Among men, both increased depression 
and anxiety symptomatology were weakly associated with decreased BMI although the 
trends were not statistically significant (Tables S1 and S2). The reverse was true among 
women: BMI was increased by 1.5 kg/m2 (P<0.001) among women with high vs. low 
anxiety symptomatology and BMI increased by 2.2 kg/m2 (p<0.001) when comparing 
women with high vs. low depression symptomatology (Tables S1 and S2). Finally, higher 
symptomatology for depression and anxiety were both associated with being a current 
smoker and having lower physical activity levels in men and women (Supplemental Tables 
S1 and S2).
Anxiety Symptoms, Depressive Symptoms and Incident Diabetes in NHANES
After multivariable adjustment, including age, race, education, smoking status, BMI and 
physical activity, there were no associations between anxiety or depressive symptoms and 
diabetes development among the full sample. The RRs for incident diabetes were as follows: 
High vs. low anxiety symptoms RR=1.07[0.69,1.67]; high vs. low depressive symptoms 
RR=1.06[0.59,1.90].
In sex specific analyses and after adjustment for age, race, education, smoking status, BMI 
and physical activity, 3rd tertile (vs. 1st) anxiety symptomatology was associated with 
increased diabetes risk among women: RR=2.19[1.17–4.09], p for trend=0.01. In contrast, 
high anxiety was non-significantly associated with lower diabetes risk among men: 
RR=0.85[0.56–1.28], p for trend=0.49 (p for sex interaction=0.005, Table 2). Similarly, 3rd 
tertile depression symptomatology (vs. 1st) was associated with increased diabetes risk 
among women but non-significantly lower risk among men (Table 3): RR among 
women=2.11[1.06–4.19], P for trend=0.03; RR among men=0.69[0.43–1.10], p for 
trend=0.12 (p for sex interaction=0.007). Results were unchanged among women in models 
additionally adjusting for postmenopausal status (data not shown).
DNHS General Characteristics
Participants were 53% female, 88% African American. Mean age±STD was 54±16 years. 
Characteristics of DNHS participants according to either depression or anxiety status are 
presented in Tables S3 and S4, Supplemental Digital Content 1.
The prevalence of diabetes in the sample was 18.3 % (n=192 cases) and was higher among 
women (20.3%) than men (15.3%), p=0.04. Mean±STD scores for GAD-7 and PHQ-9 were 
3.8±5.1and 1.5±2.1 respectively. In contrast to NHANES, women had higher (indicating 
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less symptomatology) mean±STDERR scores than men for GAD-7 (4.2±5.1 vs. 3.3±4.9, 
P<0.001) and PHQ-9 (1.7±2.2 vs. 1.2±2.0, P<0.0001).
Anxiety Symptoms, Depressive Symptoms and Prevalent Diabetes in DNHS
In the full DNHS sample, multivariable adjusted RRs for prevalent diabetes according to 
anxiety and depressive symptoms were as follows: High vs. low anxiety symptoms 
RR=1.24[0.47–3.26]; High vs. low depressive symptoms RR=1.78[1.01–3.14]. The RRs for 
high (vs. low) anxiety symptomatology predicting prevalent diabetes among men and 
women, respectively were: 0.24[0.02,2.42] and 1.62[0.61,4.32]; p for interaction<0.001. The 
RRs for high (vs. low) depression symptomatology predicting prevalent diabetes among 
men and women, respectively were: 1.30[0.46,3.68] and 2.32[1.10,4.89]; p for 
interaction=0.16. Additional sex-specific results are presented in Table 4.
DISCUSSION
We report sex differences in the relationship between depression and anxiety symptoms and 
incident diabetes during 20 years of follow-up. Risk for incident diabetes was consistently 
higher among women, but not men, with more depressive symptoms. While less robust, the 
relationship between anxiety symptoms and diabetes also differed by sex. These differences 
were not explained by sex differences in putative diabetes risk factors and were largely 
consistent across measures of both depression and anxiety.
The observed patterns in NHANES were similar to those in a separate cohort of participants 
enrolled in the Detroit Neighborhood Health Study, which is an important strength of this 
report. Although the DNHS analysis considers prevalent diabetes, the observation of 
consistent trends in both DNHS and NHANES minimizes the potential for false-positive, 
chance findings in regard to the observed sex interaction. Moreover, the potential for biases 
related to age, period or cohort effects are reduced because NHANES and DNHS are two 
distinctly different study samples with enrollment times separated by thirty years. The high 
prevalence of African American participants in DNHS increases the generalizability of the 
finding as African Americans were underrepresented in the NHANES I sample. Although 
the DNHS sex by depression interaction was not statistically significant, the sample size was 
much lower in DNHS relative to NHANES where the interaction was significant; 
nevertheless, the sex by anxiety interaction was statistically significant in DNHS (and 
NHANES).
Both depression and anxiety have been previously linked to diabetes risk but to our 
knowledge, this is the first study to show clear sex-specific findings in two separate 
population-based cohorts. Interestingly, a previous report regarding depression and diabetes 
was published from NHANES noting evidence for stronger results among women, but sex 
specific results were not presented and sex by anxiety interactions also were not tested (4). 
Moreover, that analysis included 3,081 participants who did not receive a baseline diabetes 
questionnaire raising the possibility that reverse causality might explain their observed 
findings (i.e., unascertained baseline diabetes actually preceded, and caused, depression but 
was mistakenly determined to be incident). Our current report restricts the analysis to 
individuals who received a baseline diabetes questionnaire.
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Examining the potential for sex interactions is important as it has been hypothesized that 
stress and poor mental health might portend different health outcomes for women than men 
(27,29,30,31). Several possible explanations exist, such as sex differences in coping 
mechanisms or differential biological responses to depression or anxiety including 
inflammatory response and/or hypothalamic-pituitary-adrenal (HPA) axis dysregulation.
It has been shown that men and women often display different coping styles in responses to 
stress and distress that might contribute to differential diabetes risk factor profiles. For 
example, men tend to distract themselves from mood by becoming aggressive and 
participating in activities while women are more likely to ruminate, decrease physical 
activity and eat more (45,27,29,46). Mikolajczyk and colleagues report that females – but 
not males – with depressive symptoms are more likely to consume sweets and fast foods but 
less likely to consume fruits/vegetables (47). Sex differences of this nature could therefore 
lead to increased adiposity among women but not men. The current results from NHANES 
provide modest support for this notion as small BMI increases (~10%) were observed 
among women with anxiety or depression symptoms but not among men. Nevertheless, the 
qualitative evidence for BMI mediation (or confounding) was modest in the NHANES data, 
as the results were not meaningfully changed after BMI adjustment.
Alternatively, depression and anxiety are possible sources of hypothalamic-pituitary-adrenal 
(HPA) axis dysregulation (31) and there is evidence that HPA axis abnormalities can lead to 
insulin resistance (48). HPA axis functioning is also known to differ by sex and these 
differences emerge during the lifecourse around the same time that depression and anxiety 
prevalence begins to show sex-specific patterns (31), although it remains unknown whether 
these patterns are causally linked.
Differential inflammatory response to psychopathology is another possible explanation for 
the observed sex differences. Psychopathology has been hypothesized as a contributor to the 
establishment of a chronic pro-inflammatory state and inflammation is strongly associated 
with both insulin resistance and diabetes development. Several previous studies have found 
inflammatory stimuli such as adipose tissue (49), dietary constituents (50), environmental 
pollutants (51) and chronic infections (52,53,54) to be related to insulin resistance and/or 
diabetes risk. Interestingly, there are also data to suggest that women have an exaggerated 
inflammatory response to experimentally induced psychological stress while men’s 
inflammatory responses are blunted (30).
It is also possible that bias could have contributed to the apparently null (or possibly inverse) 
associations observed among men. One possible scenario is differential ascertainment of 
diabetes status dependent on both sex and depression or anxiety symptoms. Men with 
depressive or anxiety symptoms (vs. those with low levels) might have underreported their 
diabetes while women with depressive or anxiety symptoms over reported diabetes. 
However, the differential ascertainment would need to be substantial to change the direction 
of the association from positive to inverse. It would also require, at minimum, incident 
diabetes in NHANES to have been less frequently identified by self-report among men than 
women and the evidence for this was weak. Diagnostic bias is another possible explanation 
assuming men with less depressive or anxious symptomatology and women with more 
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symptomatology were more likely have undiagnosed baseline diabetes. If this were to occur 
the undiagnosed baseline diabetes would subsequently become diagnosed and incorrectly 
believed to be incident (23) and this would happen differentially by sex and depressive or 
anxiety symptoms. However, Knol et al. report that the role of undetected baseline diabetes 
on study results was minimal (16). Moreover, the prevalence of undiagnosed diabetes 
among U.S. adults during a similar time period (1976–1980) has been shown to be very low 
(2%)(55) which also reduces the likelihood for diagnostic bias to explain results.
The DNHS prevalent diabetes findings might have been biased by differential response 
patterns to mental health questionnaires in which truly anxious or depressed men with 
diabetes were less likely to respond to questionnaires about their anxiety and/or depressive 
symptoms accurately. While we cannot rule out this possibility, it is important to note that 
the incidence data from NHANES are not susceptible to this bias as diabetes determinations 
were made prospectively and ~75% of diabetes cases were confirmed via death certificates 
or hospitalization records. Because the DNHS data report on prevalent diabetes, it is also 
possible that reverse causality (e.g., diabetes status preceded and potentially caused 
depressive symptoms as opposed to the reverse) might explain those findings. This potential 
is supported by conclusions of a two separate meta-analyses that found depression incidence 
to be increased among individuals with vs. without diabetes (17,56).
The current analyses did not account for potential confounding by antidepressant/antianxiety 
medications and future research that addresses this limitation will be important. In addition, 
while the lack of BMI information in DNHS is an important limitation, the lack of 
meaningful attenuation of results after BMI adjustment in NHANES suggests that baseline 
adiposity might not be a strong confounder.
We have found higher levels of anxiety and depression symptomatology to be positively 
related to incident diabetes among women but not among men where findings were inverse 
but did not reach statistical significance. These results arise from a population-based sample 
of US adults who were followed longitudinally for 20 years in NHANES. The patterns 
observed in NHANES were also apparent in a separate cohort of adults enrolled in DNHS. 
While our current findings do not allow for definitive causal conclusions, they are 
biologically plausible and supported by research showing other diabetes risk factors to have 
sex-specific patterns. Future studies that can minimize the potential for diagnostic bias are 
necessary. Additional research exploring biological plausibility of these findings such as sex 
differences in diabetes risk phenotype or biological response to anxiety and depression will 
be informative. If sex differential truly exists in the association between depression or 
anxiety and diabetes, it has important implications for public health screening as well as 
clinical risk stratification and treatment decisions.
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